Jie Hong Selected Research

CC Chemokines

9/2015	Increased chemokine (C-C motif) ligand 21 expression and its correlation with osteopontin in Graves' disease.
1/2013	Chemokine (C-C motif) ligand 20, a potential biomarker for Graves' disease, is regulated by osteopontin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Hong Research Topics

Disease

40	Neoplasms (Cancer) 03/2024 - 01/2003
36	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2011
27	Insulin Resistance 12/2021 - 11/2003
23	Obesity 01/2022 - 11/2003
23	Type 2 Diabetes Mellitus (MODY) 12/2021 - 11/2003
19	Carcinogenesis 01/2023 - 01/2011
16	Inflammation (Inflammations) 09/2023 - 06/2006
13	Adenocarcinoma 10/2019 - 02/2010
11	Stomach Neoplasms (Stomach Cancer) 03/2024 - 09/2012
11	Body Weight (Weight, Body) 01/2023 - 10/2007
8	Neoplasm Metastasis (Metastasis) 04/2023 - 09/2014
8	Glucose Intolerance 12/2009 - 11/2003
6	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2020 - 06/2006
6	Coronary Artery Disease (Coronary Atherosclerosis) 10/2014 - 12/2008
5	Weight Loss (Weight Reduction) 07/2021 - 07/2017
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 11/2003
5	Atherosclerosis 09/2014 - 02/2006
4	Infections 04/2024 - 06/2006
4	Necrosis 04/2023 - 06/2013
4	COVID-19 01/2023 - 02/2021
4	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 08/2007
3	Dysbiosis 12/2023 - 01/2023
3	Adenoma (Adenomas) 01/2023 - 01/2011
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 11/2019
3	Colonic Neoplasms (Colon Cancer) 11/2019 - 08/2016
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017 - 07/2012
3	Pneumonia (Pneumonitis) 12/2015 - 06/2014
3	Graves Disease (Basedow Disease) 09/2015 - 01/2013
3	Hypertension (High Blood Pressure) 11/2011 - 10/2009
2	Wounds and Injuries (Trauma) 04/2024 - 10/2014
2	Colitis 11/2023 - 01/2023
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2020
2	Strabismus (Squint) 02/2022 - 02/2022
2	Prediabetic State (Prediabetes) 01/2022 - 01/2020
2	Lung Injury 01/2022 - 06/2014
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 01/2016
2	Diabetes Mellitus 01/2021 - 08/2009
2	Hyperglycemia 01/2020 - 08/2008
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 10/2019 - 07/2012
2	Hypoxia (Hypoxemia) 01/2019 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2019 - 09/2006

Drug/Important Bio-Agent (IBA)

32	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2003
19	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2011
18	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
14	Long Noncoding RNAIBA 01/2023 - 09/2014
10	Insulin (Novolin)FDA Link 10/2017 - 11/2003
9	Triglycerides (Triacylglycerol)IBA 01/2023 - 11/2003
9	EnzymesIBA 01/2023 - 09/2006
8	Messenger RNA (mRNA)IBA 11/2023 - 09/2014
8	CytokinesIBA 10/2023 - 06/2006
8	MicroRNAs (MicroRNA)IBA 01/2019 - 08/2011
7	RNA (Ribonucleic Acid)IBA 09/2023 - 01/2018
7	LipidsIBA 04/2023 - 11/2003
6	Small Interfering RNA (siRNA)IBA 01/2020 - 06/2006
6	titanium dioxide (Titania)FDA Link 11/2017 - 06/2013
5	Bile Acids and Salts (Bile Acids)IBA 11/2018 - 02/2010
5	AcidsIBA 01/2017 - 07/2009
5	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2016 - 06/2012
5	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016 - 02/2010
4	TitaniumIBA 10/2019 - 01/2014
4	Glipizide (Glucotrol)FDA LinkGeneric 11/2017 - 05/2013
4	Metformin (Glucophage)FDA LinkGeneric 10/2017 - 05/2013
4	Dimenhydrinate (DMH)FDA LinkGeneric 10/2015 - 01/2011
4	OsteopontinIBA 09/2015 - 01/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 01/2015
3	Nucleic AcidsIBA 01/2023 - 09/2022
3	Glutamic Acid (Glutamate)FDA Link 12/2021 - 06/2016
3	LigandsIBA 01/2021 - 01/2013
3	Hormones (Hormone)IBA 01/2021 - 10/2017
3	CateninsIBA 01/2020 - 06/2014
3	DNA (Deoxyribonucleic Acid)IBA 02/2017 - 01/2003
3	LeptinIBA 01/2017 - 12/2013
3	Histones (Histone)IBA 08/2016 - 02/2012
3	Epidermal Growth Factor (EGF)IBA 01/2016 - 09/2014
3	BerberineIBA 10/2015 - 07/2008
3	HDL CholesterolIBA 03/2015 - 01/2012
3	LDL CholesterolIBA 09/2014 - 02/2006
3	Interleukin-18 (Interleukin 18)IBA 06/2010 - 06/2006
3	AdiponectinIBA 12/2008 - 06/2006
2	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2023 - 02/2017
2	Immune Checkpoint InhibitorsIBA 11/2023 - 10/2023
2	Monoclonal AntibodiesIBA 10/2023 - 08/2016
2	Butyrates (Butyrate)IBA 01/2023 - 01/2013
2	NucleotidesIBA 10/2022 - 02/2017
2	LipopolysaccharidesIBA 01/2022 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2013
2	Glutamine (L-Glutamine)FDA Link 12/2021 - 06/2016
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2021 - 02/2006
2	Peptides (Polypeptides)IBA 01/2021 - 11/2010
2	SteroidsIBA 01/2020 - 10/2017
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 09/2005
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2019 - 07/2016
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 03/2014

Therapy/Procedure

14	Therapeutics 03/2024 - 09/2006
6	Immunotherapy 03/2024 - 02/2021
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023 - 09/2009
3	Drug Therapy (Chemotherapy) 02/2021 - 07/2017
3	Bariatric Surgery 01/2021 - 07/2017
2	Glycemic Control 11/2020 - 10/2007